LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")

Author(s):  Allen Loyd V Jr, Ashworth Lisa D

Issue:  Jan/Feb 2005 - Sterile Preparations
View All Articles in Issue

Abstract:  The Food and Drug Modernization Act of 1997 included a provision that the Food and Drug Administration (FDA) compile a list of drugs not to be compounded for humans for reasons of safety. This list came to be called the “negative list.” The list of 59 drugs was published in the Federal Register on March 8, 1999, with the intent that the list would be updated and published regularly. Although the compounding provisions in the Modernization Act were struck down in 2002, it can be argued that the list is still enforceable by the FDA, since it is included in the Compliance Policy Guidelines (CPG) of the Center for Drug Evaluation and Research (CDER). Confusingly, however, in its 2003 Report to the Nation, a different set of “safety-based withdrawals” appears.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, Lisa D. Ashworth, RPh, Food and Drug Administration, FDA, withdrawn drugs, discontinued drugs, Center for Drug Evaluation and Research, CDER, Compliance Policy Guidelines, CPGs, drug safety

Related Categories: LEGAL, DISCONTINUED FORMULATIONS, FDA

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Allen Loyd V Jr, Ashworth Lisa D Jan/Feb 2005 44-46 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A Jul/Aug 2012 294-298 Buy
PreScription: Discontinued Drugs and Drug Shortages Allen Loyd V Jr Mar/Apr 2011 92 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Drugs Banned for Use in Food Animals: An Explanation Davidson Gigi S Mar/Apr 2001 101 Buy
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Allen Loyd V Jr, Williams LaVonn A Jul/Aug 2012 350-351 Buy
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr Sep/Oct 2015 389-390 Buy